Evaluate efficacy and safety of the use of chloroquine and colchicine in the treatment of hospitalized patients for moderate or severe forms of SARS-CoV-2. Draw a clinical and laboratory profile of the disease in our country. Assess the magnitude of systemic inflammation and possible pathophysiological mechanisms of SARS-CoV-2.
The IRB approval number is 30248420.9.0000.5440 (University of Sao Paulo, Brazil)
[doi:10.25345/C52988]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: SARS-CoV-2 ; Covid-19 ; chloroquine ; colchicine ; CoronaMassKB
Principal Investigators: (in alphabetical order) |
Thiago Mattar Cunha, University of Sao Paulo, Brazil |
Submitting User: | amaraljg |
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
|
||
Biological Replicates:
|
||
Technical Replicates:
|
||
Identification Results | ||
Proteins (Human, Remapped):
|
||
Proteins (Reported):
|
||
Peptides:
|
||
Variant Peptides:
|
||
PSMs:
|
||
Quantification Results | ||
Differential Proteins:
|
||
Quantified Proteins:
|
||
Browse Dataset Files | |
FTP Download Link (click to copy):
|